Global Tech News Palestine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech News Palestine.

Press releases published on March 16, 2026

Mar. 16, 2026

Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire

Mar. 16, 2026

TTEC Debuts Fin-TTEC: A Specialized Practice Built to Power the Next Era of Fintech Growth

Indeterminate GlobeNewswire

Mar. 16, 2026

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

Indeterminate GlobeNewswire

Mar. 16, 2026

CareCloud to Ring Nasdaq Closing Bell on May 19, 2026 and Host Analyst Day at Nasdaq MarketSite in New York City

Indeterminate GlobeNewswire

Mar. 16, 2026

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

Indeterminate GlobeNewswire

Mar. 16, 2026

New Two-Year Data from Pivotal ApproaCH Trial Showing Durable Benefits of TransCon® CNP (Navepegritide) in Children with Achondroplasia Shared at ACMG 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

Indeterminate GlobeNewswire

Mar. 16, 2026

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Indeterminate GlobeNewswire

Mar. 16, 2026

VERSES® Announces Closing of Private Placement Offering of Units

Indeterminate GlobeNewswire

Mar. 16, 2026

Xunlei Limited Announces Completion of Disposition of Majority Equity Interest in Shenzhen Onething

Indeterminate GlobeNewswire

Mar. 16, 2026

Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

Bitdeer Announces February 2026 Production and Operations Update

Indeterminate GlobeNewswire

Mar. 16, 2026

AnyTech365 helps spearhead first global online anti-fraud platform

Indeterminate GlobeNewswire

Mar. 16, 2026

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Indeterminate GlobeNewswire

Mar. 16, 2026

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Indeterminate GlobeNewswire

Mar. 16, 2026

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 16, 2026

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

Indeterminate GlobeNewswire

Mar. 16, 2026

Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule

Indeterminate GlobeNewswire

Mar. 16, 2026

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Indeterminate GlobeNewswire

Mar. 16, 2026

Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Minimum Price Deficiency

Indeterminate GlobeNewswire